Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:34-40
Published online before print June 3, 2002, doi: 10.1161/01.HYP.0000022060.13995.ED
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/34    most recent
01.HYP.0000022060.13995.EDv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokuyama, H.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokuyama, H.
Right arrow Articles by Saruta, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Hypertension - basic studies

(Hypertension. 2002;40:34.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Differential Regulation of Elevated Renal Angiotensin II in Chronic Renal Ischemia

Hirobumi Tokuyama; Koichi Hayashi; Hiroto Matsuda; Eiji Kubota; Masanori Honda; Ken Okubo; Ichiro Takamatsu; Satoru Tatematsu; Yuri Ozawa; Shu Wakino; Takao Saruta

From the Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan.

Correspondence to Takao Saruta, MD, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail saruta{at}sc.itc.keio.ac.jp

The present study was undertaken to clarify the role of intrarenal angiotensin (Ang) II and its generating pathways in clipped and nonclipped kidneys of 4-week unilateral renal artery stenosis in anesthetized dogs. After 4 weeks, renal plasma flow (RPF) decreased in clipped and nonclipped kidneys (baseline, 59±3; clipped, 16±1; nonclipped, 44±2 mL/min; P<0.01, n=22). Renal Ang I levels increased only in clipped, whereas intrarenal Ang II contents were elevated in both clipped (from 0.7±0.1 to 2.0±0.2 pg/mg tissue) and nonclipped kidneys (from 0.6±0.1 to 2.5±0.3 pg/mg tissue). Intrarenal ACE activity was increased in nonclipped kidneys but was unaltered in clipped kidneys. An angiotensin receptor antagonist (olmesartan medoxomil) given into the renal artery markedly restored RPF, and dilated both afferent and efferent arterioles (using intravital videomicroscopy). Furthermore, in clipped kidneys, the elevated Ang II was suppressed by a chymase inhibitor, chymostatin (from 2.1±0.6 to 0.8±0.1 pg/mg tissue; P<0.05), but not by cilazaprilat. In nonclipped kidneys, in contrast, cilazaprilat, but not chymostatin, potently inhibited the intrarenal Ang II generation (from 2.4±0.3 to 1.5±0.2 pg/mg tissue; P<0.05). Finally, [Pro11-D-Ala12]Ang I (an inactive precursor that yields Ang II by chymase but not by ACE; 1 to 50 nmol/kg) markedly elevated intrarenal Ang II in clipped, but not in nonclipped, kidneys. In conclusion, renal Ang II contents were elevated in both clipped and nonclipped kidneys, which contributed to the altered renal hemodynamics and microvascular tone. Furthermore, the mechanisms for intrarenal Ang II generation differ, and chymase activity is enhanced in clipped kidneys, whereas ACE-mediated Ang II generation is possibly responsible for elevated Ang II contents in nonclipped kidneys.


Key Words: angiotensin II • chymase • angiotensin-converting enzyme • ischemia • nephropathy




This article has been cited by other articles:


Home page
HypertensionHome page
J. Xia and Z. Szabo
Response to Intrarenal Perfusion and Angiotensin II Levels Regulate In Vivo Angiotensin II Type 1 Receptor Imaging in the Kidney
Hypertension, June 1, 2008; 51(6): e53 - e53.
[Full Text] [PDF]


Home page
HypertensionHome page
J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo
Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis
Hypertension, February 1, 2008; 51(2): 466 - 473.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, and T. Saruta
Ca2+ Channel Subtypes and Pharmacology in the Kidney
Circ. Res., February 16, 2007; 100(3): 342 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ritz
Chymase: A Potential Culprit in Diabetic Nephropathy?
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1952 - 1954.
[Full Text] [PDF]